skip to Main Content


CentoICUFor the earliest and fastest diagnosis

CentoICU® is designed to diagnose genetic conditions that become present in the newborn or early childhood period. Many of these have overlapping phenotypes and diagnosis may have immediate implications for the treatment of newborns and children.

CentoICU® is a comprehensive NGS panel for the earliest and the fastest diagnosis of critically ill newbords and children in intensive care units of hospital. It offers;

  • Short TATs: 15 business days (CentoICU®) or 10 business days (CentoICU® FAST)
  • Add-on option of CentoArrayCyto® possible to complement copy number analysis with high density array
  • Exhaustive coverage of the coding regions within more than 800 targeted genes
  • Specialized technology that allows us to target genes that are clinically linked to the ACMG-recommended newborn screening conditions as well as conditions that have been nominated for the list
  • Earlier detection of these conditions can also result in less invasive and lower cost treatments for patients
  • Can be performed on as little as 1 CentoCard® (10 drops of blood), 1 mL EDTA blood, and 1 μg DNA
  • World-class medical reports interpreted by expert human genetics

CentoICU® is designed for analysis more than 800 genes associated with over 100 conditions. The list of included genes was developed by our expert medical team based on several selection criteria, i.e.:

  • Early onset
  • Severe disease
  • ICU related symptomatology
  • Diseases/syndromes of differential diagnostic value
Who should consider CentoICU®

Parents  and  physicians  providing  treatment  to  newborns  and  children  under  24  months  admitted  to  the  ICU  and  presenting  with  unclear  symptomatology  which  can  be  part of a genetic condition, i.e.:

Bleeding Dyathesis

Blood Abnormalities (Anemia)

Bone Fragility

Failure to Thrive

Heart Abnormality/ Arrhythmia



Ichthyosis/ Epidermolysis Bullosa

Abnormal Newborn Screening Results

Metabolic Abnormalities



Respiratory Failure

Skeletal Abnormalities/ Craniosynostosis

Skin Fragility

Unclear Seizures

What type of test results can you expect

Positive result

Indicates that a well characterized and certain disease-causing mutation was identified. This result can help to access the risk of experiencing certain symptoms and indicate the best way to treat the disease. A positive result may also identify family members who are at risk of having the mutation, therefore carrier testing may be recommended.

Inconclusive result

Indicates a change in the DNA, but this change has not been proven thus far to be associated with any disorder, To clarify the clinical significance of the variant, testing of other family members may be helpful

Negative result

Does not necessarily rule out a disorder; the patient should be managed according to clinical symptoms. Further testing may be recommended.

Genetic testing when every moment counts because life begins today

See here for more info on CentoICU®


Back To Top